BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maes M, Kanchanatawan B. In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life. CNS Spectr 2021;:1-10. [PMID: 33843548 DOI: 10.1017/S1092852921000419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Sapienza J, Spangaro M, Guillemin GJ, Comai S, Bosia M. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 2022. [DOI: 10.1007/s00406-022-01519-0] [Reference Citation Analysis]
2 Al-Hakeim HK, Al-Musawi AF, Al-Mulla A, Al-Dujaili AH, Debnath M, Maes M. The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis. PLoS One 2022;17:e0275839. [PMID: 36256663 DOI: 10.1371/journal.pone.0275839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Maes M, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Stoyanova K, Kubera M, Al-Hakeim HK. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int J Environ Res Public Health 2022;19:10362. [PMID: 36011997 DOI: 10.3390/ijerph191610362] [Reference Citation Analysis]
4 Maes M, Al-rubaye HT, Almulla AF, Al-hadrawi DS, Stoyanova K, Kubera M, Al-hakeim HK. Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.. [DOI: 10.1101/2022.07.25.22277980] [Reference Citation Analysis]
5 Thisayakorn P, Thipakorn Y, Tantavisut S, Sirivichayakul S, Maes M. Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms. BMC Psychiatry 2022;22:369. [PMID: 35641947 DOI: 10.1186/s12888-022-04021-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Maes M. The negative symptoms of schizophrenia: lessons from a precision nomothetic psychiatry approach.. [DOI: 10.1101/2022.05.26.22275663] [Reference Citation Analysis]
7 Al-musawi AF, Al-hakeim HK, Al-haboby IH, Almulla AF, Maes M. In schizophrenia, the effects of the IL-6/IL-23/Th17 axis on health-related quality of life and disabilities are partly mediated by generalized cognitive decline and the symptomatome.. [DOI: 10.1101/2022.04.30.22274531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Thisayakorn P, Thipakorn Y, Tantavisut S, Sirivichayakul S, Maes M. Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms.. [DOI: 10.1101/2022.02.28.22271663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Al-hakeim HK, Alhusseini AF, Al-dujaili AH, Debnath M, Maes M. The interleukin-6/interleukin-23/Thelper-17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: a precision nomothetic psychiatry analysis.. [DOI: 10.1101/2022.02.23.22271393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Maes M, Plaimas K, Suratanee A, Noto C, Kanchanatawan B. First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection. Cells 2021;10:2929. [PMID: 34831151 DOI: 10.3390/cells10112929] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
11 Maes M, Anderson G. False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes. Front Psychiatry 2021;12:663985. [PMID: 34220578 DOI: 10.3389/fpsyt.2021.663985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
12 Maes M, Andrés-rodríguez L, Vojdani A, Sirivichayakul S, Barbosa DS, Kanchanatawan B. In schizophrenia, chronic fatigue syndrome- and fibromyalgia-like symptoms are driven by breakdown of the paracellular pathway with increased zonulin and immune activation-associated neurotoxicity.. [DOI: 10.1101/2021.05.09.21256897] [Reference Citation Analysis]